BioForm Medical (BFRM) Announces Resignation of CFO
More News related to BFRM
- Piper Jaffray Upgrades BioForm Medical (BFRM) to Overweight; Worst of Aesthetic Storm Have Passed
- BioForm Medical Reports Financial Results for Quarter Ended September 30, 2009, First Quarter of Fiscal 2010
- Bioform Medical Announces Earnings Call on November 2, 2009, and Presentation at Upcoming Investor Conference
- BioForm Medical to Present At the Maxim Group Growth Conference
- Piper Jaffray Upgrades BioForm Medical (BFRM) to Neutral; Holding Their Own Against Larger Players
BioForm Medical, Inc. (Nasdaq: BFRM) today announced that its CFO, Derek Bertocci, tendered his resignation for the company yesterday, effective December 31, 2008.
All functional areas reporting to Mr. Bertocci will report to Steven L. Basta, Chief Executive Officer of BioForm Medical, until a replacement is appointed. Mr Bertocci’s resignation does not trigger any severance payments.
BioForm Medical, Inc., a medical aesthetics company, focuses on developing and commercializing products that are used by physicians to enhance a patient's appearance.
Related Categories
Management ChangesStocks Mentioned
-0.19Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
